<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896912436552</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896912436552</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Metaplastic Variant of Invasive Micropapillary Breast Carcinoma</article-title>
<subtitle>A Unique Triple Negative Phenotype</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Aggarwal</surname><given-names>Gitika</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896912436552">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Reid</surname><given-names>Michelle Dian</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1066896912436552">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sharma</surname><given-names>Suash</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896912436552">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896912436552"><label>1</label>Georgia Health Sciences University, Augusta, GA, USA</aff>
<aff id="aff2-1066896912436552"><label>2</label>Emory University School of Medicine, Atlanta, GA, USA</aff>
<author-notes>
<corresp id="corresp1-1066896912436552">Suash Sharma, Georgia Health Sciences University, 1120 15th Street, Augusta, GA 30912, USA Email: <email>susharma@georgiahealth.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>5</issue>
<fpage>488</fpage>
<lpage>493</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Invasive micropapillary carcinomas (IMC) and metaplastic breast carcinoma (MBC) have different clinicopathologic features. This study reports an unusual case of multifocal grade III IMC associated with MBC component in a 35-year-old woman. MBC was vimentin positive, pancytokeratin negative, and showed focal p63 positivity. Immunostains for estrogen and progesterone receptor, and fluorescence in situ hybridization for Her2/neu amplification were negative. All the left axillary lymph nodes dissected were positive for metastatic carcinoma with ductal and IMC patterns, but without metaplastic component. Postmastectomy computed tomography and magnetic resonance imaging scans showed metastases to lungs, liver, brain, and vertebrae. The biologic behavior of tumor was in accordance with histology, so that the nodal and distant metastases were testament to the underlying inherently aggressive IMC, whereas large tumor size and triple negativity reflected the features of MBC. To the best of the authors’ knowledge, this is the first report of a metaplastic variant of invasive micropapillary breast carcinoma with triple negative phenotype.</p>
</abstract>
<kwd-group>
<kwd>infiltrating ductal carcinoma</kwd>
<kwd>invasive micropapillary carcinoma</kwd>
<kwd>metaplastic breast carcinoma</kwd>
<kwd>triple negative</kwd>
<kwd>axillary lymph node metastasis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>J. L. Petersen in 1993 first described a unique pattern in breast carcinoma.<sup><xref ref-type="bibr" rid="bibr1-1066896912436552">1</xref></sup> It was noted in primary breast carcinoma as well as metastatic tumor emboli in pleural fluid and ascites. This pattern resembled open tubules surrounded by retracted stroma but without endothelial lining. Immunohistochemistry showed abluminal staining with antibody to human milk fat globulins, and electron microscopy confirmed the reversal of cell polarization. The term invasive micropapillary carcinoma (IMC) was first coined by Siriaunkgul and Tavassoli<sup><xref ref-type="bibr" rid="bibr2-1066896912436552">2</xref></sup> to describe these tumors. Currently, IMC is recognized as a rare typically aggressive variant of invasive breast carcinoma, which is distinctive in being typically triple positive but with a poor clinical outcome because of high propensity for lymphatic invasion, nodal and distant metastases.<sup><xref ref-type="bibr" rid="bibr3-1066896912436552">3</xref>,<xref ref-type="bibr" rid="bibr4-1066896912436552">4</xref></sup> In contrast, primary metaplastic breast carcinoma (MBC) is a rare specialized entity but with clinicopathologic features different from IMC. MBCs usually present with large tumor size, higher stage at presentation despite less nodal involvement, higher tumor grade, and hormone receptor negativity, requiring aggressive treatment.<sup><xref ref-type="bibr" rid="bibr5-1066896912436552">5</xref>,<xref ref-type="bibr" rid="bibr6-1066896912436552">6</xref></sup> We report an unusual case of carcinoma of breast in a 35-year-old woman with ductal, micropapillary, and metaplastic histology with myoepithelial differentiation. To the best of our knowledge, this is the first case report of a metaplastic variant of invasive micropapillary breast carcinoma with triple negative phenotype.</p>
<sec id="section1-1066896912436552">
<title>Case Report</title>
<p>A 35-year-old woman with history of left breast mass for few months was detected to have a mass lesion highly suspicious of malignancy on mammography at an outside facility. A biopsy of this mass was performed, which demonstrated poorly differentiated breast carcinoma. Gross examination of the subsequent radical mastectomy specimen revealed 2 dominant tan white firm masses, measuring 7.5 × 7.0 × 7.5 cm and 5.0 × 3.5 × 3.5 cm, involving lower inner quadrant (LIQ), and upper outer quadrant (UOQ) respectively, interconnected by ill-defined induration. Microscopic sections revealed a high-grade infiltrating ductal carcinoma (grade III) with multifocal invasive micropapillary carcinoma (UOQ; <xref ref-type="fig" rid="fig1-1066896912436552">Figure 1A</xref>), and focal metaplastic carcinoma without any heterologous elements (LIQ; <xref ref-type="fig" rid="fig1-1066896912436552">Figure 1B</xref>). The high-grade ductal and invasive micropapillary carcinoma components showed immunopositivity for epithelial membrane antigen (EMA; monoclonal; 1:100; Dako, Carpinteria, CA; <xref ref-type="fig" rid="fig2-1066896912436552">Figure 2A</xref>) and pancytokeratin (monoclonal; 1:100; Dako, Carpinteria, CA; <xref ref-type="fig" rid="fig2-1066896912436552">Figure 2B</xref>), but were negative for vimentin (monoclonal; 1:100; Dako, Carpinteria, CA) and p63 (monoclonal; 1:50; Dako, Carpinteria, CA). In contrast, the metaplastic carcinoma component showed the reverse pattern with staining for vimentin (<xref ref-type="fig" rid="fig3-1066896912436552">Figure 3A</xref>), focal nuclear immunopositivity for p63 indicating myoepithelial differentiation (<xref ref-type="fig" rid="fig3-1066896912436552">Figure 3B</xref>), and focal membranous staining for epidermal growth factor receptor (EGFR; <xref ref-type="fig" rid="fig4-1066896912436552">Figure 4</xref>). Immunostaining for estrogen receptors (ER; monoclonal; 1:50; Dako, Carpinteria, CA) and progesterone receptors (PR; monoclonal; 1:50; Dako, Carpinteria, CA) were negative. Immunohistochemical stains for ki-67 showed a labeling index of 90.5% whereas p53 index was 0.28%. Stain for smooth muscle myosin was negative. Fluorescence in situ hybridization did not show any amplification of Her2/neu (ratio = 1.0:1.0). The overall morphological and immunohistochemical features were consistent with metaplastic carcinoma arising in a background of high-grade invasive micropapillary ductal carcinoma. All the 35 left axillary lymph nodes (35/35) were positive for metastatic carcinoma with ductal and micropapillary features, but without any metaplastic features. Postmastectomy computed tomography and magnetic resonance imaging showed widespread metastases to lungs, liver, brain, and lytic vertebral bone lesions involving mainly lower thoracic and lumbar spine, and right femur. She was treated with 2 cycles of Xyotax and Xeloda chemotherapy, on NCCTG protocol 0437, 6 cycles of FEC 100 chemotherapy (5-fluorouracil, epirubicin, and cyclophosphamide), 2 cycles of carboplatin and Taxotere, along with palliative right hip radiation, but with partial response and noted disease progression.</p>
<fig id="fig1-1066896912436552" position="float">
<label>Figure 1.</label>
<caption>
<p>(A) Invasive micropapillary ductal carcinoma, with brush border on the abluminal surface (pointer; hematoxylin and eosin [H&amp;E]; ×400). (B) Metaplastic carcinoma component (H&amp;E ×400)</p>
</caption>
<graphic xlink:href="10.1177_1066896912436552-fig1.tif"/>
</fig>
<fig id="fig2-1066896912436552" position="float">
<label>Figure 2.</label>
<caption>
<p>(A) Invasive micropapillary ductal carcinoma showing epithelial membrane antigen (EMA) immunopositivity with abluminal accentuation (EMA ×200). (B) High-grade infiltrating ductal carcinoma showing pankeratin immunopositivity (AE1/AE3 ×200)</p>
</caption>
<graphic xlink:href="10.1177_1066896912436552-fig2.tif"/>
</fig>
<fig id="fig3-1066896912436552" position="float">
<label>Figure 3.</label>
<caption>
<p>(A) Metaplastic carcinoma component showing diffuse vimentin immunopositivity (vimentin ×200). (B) Metaplastic carcinoma component showing foci of p63 immunopositivity indicating myoepithelial differentiation (p63 ×400).</p>
</caption>
<graphic xlink:href="10.1177_1066896912436552-fig3.tif"/>
</fig>
<fig id="fig4-1066896912436552" position="float">
<label>Figure 4.</label>
<caption>
<p>Metaplastic carcinoma component showing membranous immunopositivity for epidermal growth factor receptor (EGFR; ×400)</p>
</caption>
<graphic xlink:href="10.1177_1066896912436552-fig4.tif"/>
</fig>
</sec>
<sec id="section2-1066896912436552">
<title>Discussion</title>
<p>Invasive micropapillary carcinoma is a rare variant of invasive ductal breast carcinoma, constituting about 2% of all invasive breast cancers, and focal micropapillary changes can be present in 3% to 6% of the common types of invasive carcinoma. IMC is distinctive in typically representing the most inherently aggressive form, even when occurring as a focal pattern in other forms of breast carcinoma.<sup><xref ref-type="bibr" rid="bibr3-1066896912436552">3</xref><xref ref-type="bibr" rid="bibr4-1066896912436552"/>-<xref ref-type="bibr" rid="bibr5-1066896912436552">5</xref>,<xref ref-type="bibr" rid="bibr7-1066896912436552">7</xref><xref ref-type="bibr" rid="bibr8-1066896912436552"/><xref ref-type="bibr" rid="bibr9-1066896912436552"/><xref ref-type="bibr" rid="bibr10-1066896912436552"/><xref ref-type="bibr" rid="bibr11-1066896912436552"/>-<xref ref-type="bibr" rid="bibr12-1066896912436552">12</xref></sup> However, when micropapillary carcinoma is associated to ductal carcinoma in situ the latter is usually well differentiated.<sup><xref ref-type="bibr" rid="bibr13-1066896912436552">13</xref></sup> IMC is morphologically characterized by nests of tumor cells in nonendothelialized retraction spaces and without fibrovascular cores, with “inside-out growth” pattern such that apical morphologic features and EMA positivity are seen on the abluminal, stroma-facing (basal) surface.<sup><xref ref-type="bibr" rid="bibr4-1066896912436552">4</xref>,<xref ref-type="bibr" rid="bibr7-1066896912436552">7</xref>,<xref ref-type="bibr" rid="bibr8-1066896912436552">8</xref>,<xref ref-type="bibr" rid="bibr11-1066896912436552">11</xref>,<xref ref-type="bibr" rid="bibr12-1066896912436552">12</xref></sup> IMCs have a high propensity for lymphatic invasion, regional nodal (69% to 95%; often more than 3 nodes) and distant metastases,<sup><xref ref-type="bibr" rid="bibr8-1066896912436552">8</xref></sup> even when the extent of micropapillary growth pattern is limited or focal,<sup><xref ref-type="bibr" rid="bibr7-1066896912436552">7</xref></sup> or in ductal carcinomas exhibiting only partial reverse cell polarity.<sup><xref ref-type="bibr" rid="bibr8-1066896912436552">8</xref>,<xref ref-type="bibr" rid="bibr11-1066896912436552">11</xref></sup> Although the exact mechanism of this aggressive behavior is unclear, the altered tumor–stromal interactions along the retraction spaces of IMC are thought to account for increased tumor invasiveness,<sup><xref ref-type="bibr" rid="bibr4-1066896912436552">4</xref>,<xref ref-type="bibr" rid="bibr8-1066896912436552">8</xref></sup> as evidenced by the absence of E-cadherin and upregulation of N-cadherin at the interface between the cytoplasmic membrane and the stroma<sup><xref ref-type="bibr" rid="bibr9-1066896912436552">9</xref>,<xref ref-type="bibr" rid="bibr10-1066896912436552">10</xref></sup> and, recently reported cytoplasmic expression of p63, possibly contributing to dysregulation of epithelial–myoepithelial balance.<sup><xref ref-type="bibr" rid="bibr12-1066896912436552">12</xref></sup></p>
<p>Metaplastic breast carcinoma is a rare heterogeneous tumor of mammary origin that is morphologically characterized by squamous, cytokeratin positive homologous spindle cell, and/or mesenchymal phenotype with or without a coexistent conventional adenocarcinoma component.<sup><xref ref-type="bibr" rid="bibr6-1066896912436552">6</xref>,<xref ref-type="bibr" rid="bibr14-1066896912436552">14</xref></sup> The World Health Organization has classified MBC into pure epithelial type (subclassified as squamous cell carcinoma, adenocarcinoma with spindle cell differentiation, and adenosquamous carcinoma including mucoepidermoid carcinoma), and mixed epithelial/mesenchymal types (subclassified into carcinoma with chondroid metaplasia, carcinoma with osseous metaplasia, and carcinosarcoma).<sup><xref ref-type="bibr" rid="bibr6-1066896912436552">6</xref>,<xref ref-type="bibr" rid="bibr14-1066896912436552">14</xref></sup> Immunohistochemically, MBC shows a reverse pattern of staining for pancytokeratin (AE1/AE3) and vimentin in carcinomatous and spindle cell component, respectively, as noted in the current case. In addition, positivity for smooth muscle actin, calponin, CD10, and p63 in spindle cells indicate myoepithelial differentiation,<sup><xref ref-type="bibr" rid="bibr6-1066896912436552">6</xref>,<xref ref-type="bibr" rid="bibr15-1066896912436552">15</xref>,<xref ref-type="bibr" rid="bibr16-1066896912436552">16</xref></sup> which help distinguish MBC from sarcomas such as leiomyosarcoma, angiosarcoma, and liposarcoma.</p>
<p>Clinically, IMCs are usually irregular and ill-defined lobulated masses with high density and microcalcifications on mammograms, a solid irregular and ill-defined hypoechoic mass with frequent axillary nodal involvement on ultrasound, and a multifocal mass on magnetic resonance imaging.<sup><xref ref-type="bibr" rid="bibr3-1066896912436552">3</xref></sup> In contrast, MBCs usually present in individuals older than 50 years with rapidly growing single palpable nodule,<sup><xref ref-type="bibr" rid="bibr5-1066896912436552">5</xref>,<xref ref-type="bibr" rid="bibr7-1066896912436552">7</xref></sup> and mammographically as dense round, lobular, or oval noncalcified lesions with circumscribed margins,<sup><xref ref-type="bibr" rid="bibr17-1066896912436552">17</xref>,<xref ref-type="bibr" rid="bibr18-1066896912436552">18</xref></sup> which are relatively larger (mean = 3.9 cm) compared with invasive ductal carcinomas (range = 1.2-10 cm) at diagnosis.<sup><xref ref-type="bibr" rid="bibr5-1066896912436552">5</xref>,<xref ref-type="bibr" rid="bibr17-1066896912436552">17</xref></sup> An outside mammography in our patient demonstrated an ill-defined mass highly suspicious for malignancy.</p>
<p>Our study highlights 2 unusual findings in IMC: a metaplastic component and triple negative phenotype. In the literature, MBC is known to exhibit a basal/myoepithelial molecular and immunophenotype with expression of EGFR, CK14, CK5/6, and p63 and negativity for ER, PR, and HER2.<sup><xref ref-type="bibr" rid="bibr6-1066896912436552">6</xref>,<xref ref-type="bibr" rid="bibr14-1066896912436552">14</xref>,<xref ref-type="bibr" rid="bibr19-1066896912436552">19</xref>,<xref ref-type="bibr" rid="bibr20-1066896912436552">20</xref></sup> However, IMC has not been shown to exhibit basal-like phenotype.<sup><xref ref-type="bibr" rid="bibr12-1066896912436552">12</xref>,<xref ref-type="bibr" rid="bibr21-1066896912436552">21</xref></sup> Yet there are isolated examples of variable mesenchymal differentiation in IMC. One case of IMC in a recent study showed coexpression of CK8/18 (epithelial markers), EMA, and vimentin (mesenchymal marker).<sup><xref ref-type="bibr" rid="bibr12-1066896912436552">12</xref></sup> To the best of our knowledge, our study is the first report of a primary MBC arising in an IMC, with focal p63 and EGFR staining suggesting basal-like features in MBC component. The only other reported case of IMC and myoepithelial carcinoma occurred in different breasts.<sup><xref ref-type="bibr" rid="bibr16-1066896912436552">16</xref></sup></p>
<p>Regarding hormone receptor status, MBC are known to be generally negative for ER, PR, and Her2/neu.<sup><xref ref-type="bibr" rid="bibr5-1066896912436552">5</xref>,<xref ref-type="bibr" rid="bibr22-1066896912436552">22</xref></sup> However, there are some reports of positivity for ER and PR ranging from 0% to 17% and HER2/neu expression of 4% to 16%.<sup><xref ref-type="bibr" rid="bibr23-1066896912436552">23</xref></sup> IMCs usually demonstrate a triple positive profile with a high percentage of positivity for ER and PR, and Her2/neu oncoprotein.<sup><xref ref-type="bibr" rid="bibr4-1066896912436552">4</xref>,<xref ref-type="bibr" rid="bibr7-1066896912436552">7</xref>,<xref ref-type="bibr" rid="bibr24-1066896912436552">24</xref></sup> Exceptions in IMC include a recent report in which 4 cases were found to be negative for the ER/PR/HER2 despite the lack of any basal-like features.<sup><xref ref-type="bibr" rid="bibr12-1066896912436552">12</xref></sup> Our case was triple negative for ER, PR, as well as Her2/neu.</p>
<p>In our study, 100% of the 35 lymph nodes dissected in showed tumor metastasis. Since the lymph nodes mostly showed high-grade ductal and micropapillary areas, we believe that this high rate of metastasis likely reflects the known aggressive biologic potential of IMC as compared with MBC.<sup><xref ref-type="bibr" rid="bibr4-1066896912436552">4</xref>,<xref ref-type="bibr" rid="bibr24-1066896912436552">24</xref>,<xref ref-type="bibr" rid="bibr25-1066896912436552">25</xref></sup> The axillary lymph node involvement in MBC has been reported to have a lower incidence (6% to 31%) compared with similar sized ductal carcinomas of breast,<sup><xref ref-type="bibr" rid="bibr5-1066896912436552">5</xref>,<xref ref-type="bibr" rid="bibr23-1066896912436552">23</xref></sup> being more frequent in carcinosarcoma variant.<sup><xref ref-type="bibr" rid="bibr26-1066896912436552">26</xref>,<xref ref-type="bibr" rid="bibr27-1066896912436552">27</xref></sup> The lack of MBC in axillary nodes in our report may be a reflection of its known lower incidence of nodal involvement.<sup><xref ref-type="bibr" rid="bibr5-1066896912436552">5</xref></sup> Alternatively, it may reflect its later evolution as dedifferentiation at the primary site in a preexisting high-grade ductal and invasive micropapillary carcinoma, as proposed recently.<sup><xref ref-type="bibr" rid="bibr6-1066896912436552">6</xref></sup> Furthermore, the location of IMC in UOQ may have facilitated its earlier spread to axillary nodes as compared with MBC in LIQ.</p>
<p>Although the principles of treatment are same as infiltrating ductal carcinoma, both IMC and MBC are treated more aggressively (more often with mastectomy and chemotherapy); IMC because of high frequency of lymph node involvement,<sup><xref ref-type="bibr" rid="bibr4-1066896912436552">4</xref>,<xref ref-type="bibr" rid="bibr5-1066896912436552">5</xref></sup> whereas MBC because of higher tumor stage resulting from larger tumor size (despite less nodal involvement), higher tumor grade, and hormone receptor negativity. Recent studies have shown that despite adjuvant chemotherapy, MBC is prone to recurrences, and had a poorer prognosis than triple negative invasive ductal carcinoma, especially in patients with nodal metastasis.<sup><xref ref-type="bibr" rid="bibr23-1066896912436552">23</xref>,<xref ref-type="bibr" rid="bibr27-1066896912436552">27</xref></sup> Our case was treated with multiagent chemotherapy but with only partial response and noted disease progression.</p>
<p>In summary, we report an unusual metaplastic variant of invasive micropapillary breast carcinoma with triple negative phenotype. The biologic behavior of tumor was in accordance with the histology, so that the axillary nodal and distant metastases were testament to the underlying inherently aggressive IMC, whereas large tumor size and triple negativity reflected the features of MBC. To the best of our knowledge, this is the first case report of a metaplastic variant of invasive micropapillary breast carcinoma with triple negative phenotype.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896912436552">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petersen</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Breast carcinoma with an unexpected inside out growth pattern: rotation of polarization associated with angioinvasion</article-title>. <source>Pathol Res Pract</source>. <year>1993</year>;<volume>189</volume>:<fpage>780</fpage>.</citation>
</ref>
<ref id="bibr2-1066896912436552">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Siriaunkgul</surname><given-names>S</given-names></name>
<name><surname>Tavassoli</surname><given-names>FA</given-names></name>
</person-group>. <article-title>Invasive micropapillary carcinoma of the breast</article-title>. <source>Mod Pathol</source>. <year>1993</year>;<volume>6</volume>:<fpage>660</fpage>-<lpage>662</lpage>.</citation>
</ref>
<ref id="bibr3-1066896912436552">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adrada</surname><given-names>B</given-names></name>
<name><surname>Arribas</surname><given-names>E</given-names></name>
<name><surname>Gilcrease</surname><given-names>M</given-names></name>
<name><surname>Yang</surname><given-names>WT</given-names></name>
</person-group>. <article-title>Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and MRI features</article-title>. <source>AJR Am J Roentgenol</source>. <year>2009</year>;<volume>193</volume>:<fpage>W58</fpage>-<lpage>W63</lpage>.</citation>
</ref>
<ref id="bibr4-1066896912436552">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nassar</surname><given-names>H</given-names></name>
</person-group>. <article-title>Carcinomas with micropapillary morphology: clinical significance and current concepts</article-title>. <source>Adv Anat Pathol</source>. <year>2004</year>;<volume>11</volume>:<fpage>297</fpage>-<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr5-1066896912436552">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pezzi</surname><given-names>CM</given-names></name>
<name><surname>Patel-Parekh</surname><given-names>L</given-names></name>
<name><surname>Cole</surname><given-names>K</given-names></name>
<name><surname>Franko</surname><given-names>J</given-names></name>
<name><surname>Klimberg</surname><given-names>VS</given-names></name>
<name><surname>Bland</surname><given-names>K</given-names></name>
</person-group>. <article-title>Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base</article-title>. <source>Ann Surg Oncol</source>. <year>2007</year>;<volume>14</volume>:<fpage>166</fpage>-<lpage>173</lpage>.</citation>
</ref>
<ref id="bibr6-1066896912436552">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van Deurzen</surname><given-names>CHM</given-names></name>
<name><surname>Lee</surname><given-names>AHS</given-names></name>
<name><surname>Gill</surname><given-names>MS</given-names></name>
<etal/>
</person-group>. <article-title>Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation?</article-title> <source>J Pathol</source>. <year>2011</year>;<volume>224</volume>:<fpage>434</fpage>-<lpage>437</lpage>.</citation>
</ref>
<ref id="bibr7-1066896912436552">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walsh</surname><given-names>MM</given-names></name>
<name><surname>Bleiweiss</surname><given-names>IJ</given-names></name>
</person-group>. <article-title>Invasive micropapillary carcinoma of the breast: eighty cases of an under-recognized entity</article-title>. <source>Hum Pathol</source>. <year>2001</year>;<volume>32</volume>:<fpage>583</fpage>-<lpage>589</lpage>.</citation>
</ref>
<ref id="bibr8-1066896912436552">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Acs</surname><given-names>G</given-names></name>
<name><surname>Esposito</surname><given-names>NN</given-names></name>
<name><surname>Rakosy</surname><given-names>Z</given-names></name>
<name><surname>Laronga</surname><given-names>C</given-names></name>
<name><surname>Zhang</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma</article-title>. <source>Am J Surg Pathol</source>. <year>2010</year>;<volume>34</volume>:<fpage>1637</fpage>-<lpage>1646</lpage>.</citation>
</ref>
<ref id="bibr9-1066896912436552">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nagi</surname><given-names>C</given-names></name>
<name><surname>Guttman</surname><given-names>M</given-names></name>
<name><surname>Jaffer</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>N-cadherin expression in breast cancer: correlation with an aggressive histologic variant of invasive micropapillary carcinoma</article-title>. <source>Breast Cancer Res Treat</source>. <year>2005</year>;<volume>94</volume>:<fpage>225</fpage>-<lpage>235</lpage>.</citation>
</ref>
<ref id="bibr10-1066896912436552">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pettinato</surname><given-names>G</given-names></name>
<name><surname>Manivel</surname><given-names>CJ</given-names></name>
<name><surname>Panico</surname><given-names>L</given-names></name>
<name><surname>Sparano</surname><given-names>L</given-names></name>
<name><surname>Petrella</surname><given-names>G</given-names></name>
</person-group>. <article-title>Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior</article-title>. <source>Am J Clin Pathol</source>. <year>2004</year>;<volume>121</volume>:<fpage>857</fpage>-<lpage>866</lpage>.</citation>
</ref>
<ref id="bibr11-1066896912436552">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuba</surname><given-names>S</given-names></name>
<name><surname>Ohtani</surname><given-names>H</given-names></name>
<name><surname>Yamaguchi</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survival</article-title>. <source>Virchows Arch</source>. <year>2011</year>;<volume>458</volume>:<fpage>159</fpage>-<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr12-1066896912436552">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamaguchi</surname><given-names>R</given-names></name>
<name><surname>Tanaka</surname><given-names>M</given-names></name>
<name><surname>Kondo</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis</article-title>. <source>Jpn J Clin Oncol</source>. <year>2010</year>;<volume>40</volume>:<fpage>781</fpage>-<lpage>787</lpage>.</citation>
</ref>
<ref id="bibr13-1066896912436552">
<label>13.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Tavassoli</surname><given-names>FA</given-names></name>
<name><surname>Eusebi</surname><given-names>V</given-names></name>
</person-group>. <source>Tumors of the Breast</source>. <edition>4th ed.</edition> <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Registry of Pathology/Armed Forces Institute of Pathology</publisher-name>; <year>2009</year>.</citation>
</ref>
<ref id="bibr14-1066896912436552">
<label>14.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Ellis</surname><given-names>IO</given-names></name>
<name><surname>Schnitt</surname><given-names>SJ</given-names></name>
<name><surname>Sastre-Garau</surname><given-names>X</given-names></name>
<etal/>
</person-group>. <article-title>Invasive breast carcinoma</article-title>. In: <person-group person-group-type="editor">
<name><surname>Tavassoli</surname><given-names>FA</given-names></name>
<name><surname>Devilee</surname><given-names>P</given-names></name>
</person-group>, eds. <source>World Health Organization Classification of Tumors: Tumors of the Breast and Female Genital Organs</source>. <publisher-loc>Lyon, France</publisher-loc>: <publisher-name>IARC Press</publisher-name>; <year>2003</year>:<fpage>35</fpage>-<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr15-1066896912436552">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leibl</surname><given-names>S</given-names></name>
<name><surname>Moinfar</surname><given-names>F</given-names></name>
</person-group>. <article-title>Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation</article-title>. <source>Am J Surg Pathol</source>. <year>2006</year>;<volume>30</volume>:<fpage>450</fpage>-<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr16-1066896912436552">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kwon</surname><given-names>SY</given-names></name>
<name><surname>Bae</surname><given-names>YK</given-names></name>
<name><surname>Cho</surname><given-names>J</given-names></name>
<name><surname>Kang</surname><given-names>SH</given-names></name>
</person-group>. <article-title>Myoepithelial carcinoma with contralateral invasive micropapillary carcinoma of the breast</article-title>. <source>J Korean Surg Soc</source>. <year>2011</year>;<volume>81</volume>:<fpage>211</fpage>-<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr17-1066896912436552">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>WT</given-names></name>
<name><surname>Hennessy</surname><given-names>B</given-names></name>
<name><surname>Broglio</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Imaging differences between metaplastic and invasive ductal carcinomas of the breast</article-title>. <source>AJR Am J Roentgenol</source>. <year>2007</year>;<volume>189</volume>:<fpage>1288</fpage>-<lpage>1293</lpage>.</citation>
</ref>
<ref id="bibr18-1066896912436552">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Patterson</surname><given-names>KS</given-names></name>
<name><surname>Tworek</surname><given-names>JA</given-names></name>
<name><surname>Roubidoux</surname><given-names>MA</given-names></name>
<name><surname>Helvie</surname><given-names>MA</given-names></name>
<name><surname>Oberman</surname><given-names>HA</given-names></name>
</person-group>. <article-title>Metaplastic carcinoma of the breast: mammographic appearance with pathologic correlation</article-title>. <source>AJR Am J Roentgenol</source>. <year>1997</year>;<volume>169</volume>:<fpage>709</fpage>-<lpage>712</lpage>.</citation>
</ref>
<ref id="bibr19-1066896912436552">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weigelt</surname><given-names>B</given-names></name>
<name><surname>Kreike</surname><given-names>B</given-names></name>
<name><surname>Reis-Filho</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis</article-title>. <source>Breast Cancer Res Treat</source>. <year>2009</year>;<volume>117</volume>:<fpage>273</fpage>-<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr20-1066896912436552">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reis-Filho</surname><given-names>JS</given-names></name>
<name><surname>Milanezi</surname><given-names>F</given-names></name>
<name><surname>Steele</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Metaplastic breast carcinomas are basal-like tumors</article-title>. <source>Histopathology</source>. <year>2006</year>;<volume>49</volume>:<fpage>10</fpage>-<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr21-1066896912436552">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>MJ</given-names></name>
<name><surname>Gong</surname><given-names>G</given-names></name>
<name><surname>Joo</surname><given-names>HJ</given-names></name>
<name><surname>Ahn</surname><given-names>SH</given-names></name>
<name><surname>Ro</surname><given-names>JY</given-names></name>
</person-group>. <article-title>Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component</article-title>. <source>Arch Pathol Lab Med</source>. <year>2005</year>;<volume>129</volume>:<fpage>1277</fpage>-<lpage>1282</lpage>.</citation>
</ref>
<ref id="bibr22-1066896912436552">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beatty</surname><given-names>JD</given-names></name>
<name><surname>Atwood</surname><given-names>M</given-names></name>
<name><surname>Tickman</surname><given-names>R</given-names></name>
<name><surname>Reiner</surname><given-names>M</given-names></name>
</person-group>. <article-title>Metaplastic breast cancer: clinical significance</article-title>. <source>Am J Surg</source>. <year>2006</year>;<volume>191</volume>:<fpage>657</fpage>-<lpage>664</lpage>.</citation>
</ref>
<ref id="bibr23-1066896912436552">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lester</surname><given-names>TR</given-names></name>
<name><surname>Hunt</surname><given-names>KK</given-names></name>
<name><surname>Nayeemuddin</surname><given-names>KM</given-names></name>
<etal/>
</person-group>. <article-title>Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers</article-title>. <source>Breast Cancer Res Treat</source>. <year>2012</year>;<volume>131</volume>:<fpage>41</fpage>-<lpage>48</lpage>. doi:10.1007/s10549-011-1393-6<pub-id pub-id-type="doi">10.1007/s10549-011-1393-6</pub-id>.</citation>
</ref>
<ref id="bibr24-1066896912436552">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zekioglu</surname><given-names>O</given-names></name>
<name><surname>Erhan</surname><given-names>Y</given-names></name>
<name><surname>Ciris</surname><given-names>M</given-names></name>
<name><surname>Bayramoglu</surname><given-names>H</given-names></name>
<name><surname>Ozdemir</surname><given-names>N</given-names></name>
</person-group>. <article-title>Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma</article-title>. <source>Histopathology</source>. <year>2004</year>;<volume>44</volume>:<fpage>18</fpage>-<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr25-1066896912436552">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hennessy</surname><given-names>BT</given-names></name>
<name><surname>Giordano</surname><given-names>S</given-names></name>
<name><surname>Broglio</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Biphasic metaplastic sarcomatoid carcinoma of the breast</article-title>. <source>Ann Oncol</source>. <year>2006</year>;<volume>17</volume>:<fpage>605</fpage>-<lpage>613</lpage>.</citation>
</ref>
<ref id="bibr26-1066896912436552">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barnes</surname><given-names>PJ</given-names></name>
<name><surname>Boutilier</surname><given-names>R</given-names></name>
<name><surname>Chiasson</surname><given-names>D</given-names></name>
<name><surname>Rayson</surname><given-names>D</given-names></name>
</person-group>. <article-title>Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression</article-title>. <source>Breast Cancer Res Treat</source>. <year>2005</year>;<volume>91</volume>:<fpage>173</fpage>-<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr27-1066896912436552">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bae</surname><given-names>SY</given-names></name>
<name><surname>Lee</surname><given-names>SK</given-names></name>
<name><surname>Koo</surname><given-names>MY</given-names></name>
<etal/>
</person-group>. <article-title>The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients</article-title>. <source>Breast Cancer Res Treat</source>. <year>2011</year>;<volume>126</volume>:<fpage>471</fpage>-<lpage>478</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>